Adenovirus supervector system

Details Adenovirus supervector system Adenovirus supervector system

2007-08-07

2007-08-07

Crouch, Deborah (Department: 1632)

Chemistry: molecular biology and microbiology

Vector, per se

C536S023100

Reexamination Certificate

active

08222285

ABSTRACT:
An adenoviral supervector system is disclosed that is capable of expressing more than 7.5 kilobases of heterologous DNA in a replication defective adenoviral vector. The supervector system comprises an adenoviral vector construct and a helper cell. The vector construct is capable of being replicated and packaged into a virion particle in the helper cell. In particular, the helper cell expresses DNA from the E2 region of the adenovirus 5 genome and complements deletions in that region in the vector construct.In certain embodiments, the disclosed invention comprises tissue specific expression of up to 30 kb of heterologous DNA directed by an adenoviral vector. Also disclosed are methods of transferring heterologous DNA into mammalian cells.

REFERENCES:
patent: 4683202 (1987-07-01), Mullis
patent: 2688514 (1993-09-01), None
patent: WO 93/03769 (1993-03-01), None
patent: WO 94/10323 (1994-05-01), None
patent: WO 94/24297 (1994-10-01), None
patent: WO 95/02697 (1995-01-01), None
patent: WO 95/29993 (1995-11-01), None
Newalt et al., Behavioral and Brain Sciences, 18 : 1-9 (1995).
Wolff, Current Biology, 3 : 743-748 (1993).
Yang et al., Proc. Natl. Acad. Sci. USA, 91(10):4407-4411 (1994).
Graham et al, Methods in Molecular Biology, 7:109-128 (1991).
Davidson et al, Nature Genetics, 3:219-223 (1993).
Engelhardt et al, Proc. Natl. Acad. Sci. USA, 91:6196-6200 (1994).
Klessig et al, Molecular and Cellular Biology, 4(7):1354-1362 (1984).
Wang et al. (1996) Nature Med. 2, 714-716.
Brough et al. (1992) Viral. 190, 624-634.
Berkner, K.L. Development of adenovirus vectors for the expression of heterologous genes.BioTechniques6:616-629, 1988.
Blau, “Muscling in on gene therapy”,Nature, 364:673-675, 1993.
Bridge, E., S. Medghalchi, S. Ubol, M. Leesong, and G. Ketner. Adenovirus early region 4 and viral DNA synthesis.Virology193:794-801, 1993.
Friedmann, T. Gene therapy of cancer through restoration of tumor-suppressor functions?CANCER70(Suppl) :1810-1817, 1992.
Glorioso, J.G., W.F. Goins, and D.J. Fink. Herpes simplex virus-based vectors.Semin. Virol.3:265-276, 1992.
Gomez-Foix, A.M., W.S. Coats, S. Baque, T. Alam, R.D. Gerard, and C.B. Newgard. Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen.J. Biol. Chem.267:25129-25134, 1992.
Graham, F.L., and L. Prevec. Adenovirus-based expression vectors and recombinant vaccines.Biotechnology20:363-390, 1992.
Grunhaus, A., and M.S. Horwitz. Adenoviruses as cloning vectors.Semin. Virol.3:237-252, 1992.
Hearing, P., R.J. Samulski, W.L. Wishart, and T. Shenk. Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome.J. Virol.61:2555-2558, 1987.
Hermonat, P.L., and N. Muzyczka. Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells.Proc. Natl. Acad. Sci. USA81:6466-6470, 1984.
Herz, J., and R.D. Gerard. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice.Proc. Natl. Acad. Sci. USA90:2812-2816, 1993.
Jaffe et al., “Adenovirus-mediated in vivo gene transfer and expression in normal rat liver”,Nature Genetics, 1:372-378, 1992.
Ketner et al., “Complementation of adenovirus E4 mutants by transient expression of E4 cDNA and deletion plasmids”, Nucleic Acids Research 17:3037-3048, 1989.
Le Gal La Salle, G., J.J. Robert, S. Berrard, V. Ridoux, L.D. Stratford-Perricaudet, M. Perricaudet, and J. Mallet. An adenovirus vector for gene transfer into neurons and glia in the brain.Science259:988-990, 1993.
Majors, J.E. Retrovirol vector-strategies and applicaitons.Semin. Virol.3:285-295, 1992.
McGrory, W.J., D. S. Bautista, and F.L. Graham. A simple technique for the rescue of early region 1 mutations into infectious human adenovirus type 5.Virology163:614-617, 1988.
Miller, A.D. Human gene therapy comes of age.Nature357:455-460, 1992.
Morgan, R.A., L. Couture, O. Elroy-Stein, J. Ragheb, B. Moss, and W.F. Anderson. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy.Nucleic Acids Res.20:1293-1299, 1992.
Mulligan, R.C. The basic science of gene therapy.Science260:9260-932, 1993.
Prevec et al., “Use of Human Adenovirus-based Vectors for Antigen Expression in Animals”,J. gen. Virol., 70:429-434, 1989.
Ragot, T., N. Vincent, P. Chafey, E. Vigne, H. Gilgenkrantz, D. Couton, J. Cartaud, P. Briand, J.-C. Kaplan, M. Perricaudet, and A. Kahn. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle ofmdxmice.Nature361:647-650, 1993.
Renan, M.J. Cancer genes: current status, future prospects, and applicants in radiotherapy/oncology.Radiother. Oncol.19:197-218, 1990.
Rich, D.P., L.A. Couture, L.M. Cardoza, V.M. Guiggio, D. Armentano, P.C. Espino, K.Hehir, M.J. Welsh, A.E. Smith, and R.J. Gregory. Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis.Hum. Gene Ther.4:461-476, 1993.
Rosenfeld, M.A., K. Yoshimura, B.C. Trapnell, K. Yoneyama, E.R. Rosenthal, W. Dalemans, M. Fukayama, J. Bargon, L.E. Stier, L. Stratford-Perricaudet, M. Perricaudet, W. B. Guggino, A. Pavirani, J.-P. Lecocq, and R.G. Crystal. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium.Cell68:143-155, 1992.
Rosenfeld, M.A., W. Siegfried, K. Yoshimura, K. Yoneyama, M. Fukayama, L.E. Stier, P.K. Paakko, P. Gilardi, L. Stratford-Perricaudet, M. Perricaudet, S. Jallat, A. Pavirani, J.-P. Lecocq, and R.G. Crystal. Adenovirus-mediated transfer of a recombinant α1-antitrypsin gene to the lung epithelium in vivo.Science252:431-434, 1991.
Stratford-Pericaudet et al., “Feasibility of adenovirus-mediated gene transfer in vivo”,Bone Marrow Transplantation, 9 (Suppl. 1) :151-152, 1992.
Stratford-Perricaudet et al., “Widespread Long-term Gene Transfer to Mouse Skeletal Muscles and Heart”,J. Clin. Invest., 90:626-630, 1992.
Stratford-Perricaudet, L.D, M. Perricaudet, and P. Briand. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector.Hum. Gene Ther.1:241-256, 1990.
Su, W., T. Middleton, B. Sugden, and H. Echols. DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen I.Proc. Natl. Acad. Sci. USA88:10870-10874, 1991.
Zhang, W.-W., X. Fang, C.D. Branch, W. Mazur, B.A. French, and J.A. Roth. Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis.BioTechiques15:868-872, 1993.
Casey et al., “Growth Suppression of Human Breast Cancer Cells by the Introduction of a Wild-Type p53 Gene,”Oncogene, 6:1791-1797, 1991.
Wills and Menzel, “Adenovirus Vectors for Gene Therapy of Cancer,”Journal of Cellular Biochemistry, p. 204, Abstract # S216, Mar.-Apr. 1993.
Carter et al., “Adenovirus Containing a Deletion of the Early Region 2A Gene Allows Growth of Adeno-Associated Virus with Decreased Efficiency,”Virology, 191:473-476, 1992.
Bacchetti, et al, “Inhibition of Cell Proliferation by and Adenovirus Vector Expressing the Human Wild Type p53 Protein,”International Journal of Oncology, 3:781-788, 1993.
Bowtell et al., “Comparison of Expression in Hemopoietic Cells by Retroviral Vectors Carrying Two Genes,”Journal of Virology, 62(7):2464-2473, 1988.
Cai et al., “Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer,”Hum. Gene Ther., 4:617-24, 1993.
Chiao et al., “The current state of oncogenes and cancer: experimental approaches for analyzing oncogenetic events in human cancer,”Cancer and Metastasis Review, 9:63-80, 1990.
Colicos et al., Construction of a recombinant adenovirus c

Affiliated with

Also associated with

Rating

Adenovirus supervector system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adenovirus supervector system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenovirus supervector system will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3870993